Etonogestrel

CHEMBL1531 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
324.5 g/mol
LogP
3.3
Phase
4

This synthetic progestogen releases slowly from a subdermal implant or vaginal ring to provide highly effective long-term contraception by preventing ovulation. It can also be used in certain hormonal therapies.

Peso Molecular

324,5000 g/mol

LogP

3,30

TPSA

37,30 Ų

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3C(=C)C[C@@]21CC

InChI

InChI=1S/C22H28O2/c1-4-21-13-14(3)20-17-9-7-16(23)12-15(17)6-8-18(20)19(21)10-11-22(21,24)5-2/h2,12,17-20,24H,3-4,6-11,13H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1

Molecular Formula

C22H28O2

HBD / HBA

1 / 2

Ligações Rotacionáveis

2

Átomos Pesados

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

This synthetic progestogen releases slowly from a subdermal implant or vaginal ring to provide highly effective long-term contraception by preventing ovulation. It can also be used in certain hormonal therapies.

Yes, Etonogestrel is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1531. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6917715. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.